A major retail pharmacy chain has reached a $50 million settlement with the federal government to resolve allegations that its pharmacies improperly filled hundreds of thousands of prescriptions for controlled substances, contributing to the opioid epidemic. The lawsuit, filed in 2020, accused the company of neglecting to report suspicious drug orders, raising concerns about its role in the crisis. The agreement marks a conclusion to the federal case but underscores ongoing scrutiny over pharmacy practices in the fight against prescription drug abuse. Authorities say the case highlights systemic failures in monitoring high-risk prescriptions.
Walmart has agreed to pay $50 million to settle a lawsuit claiming that its pharmacies filled hundreds of thousands of illegal prescriptions for controlled substances that fueled the opioid crisis, the Justice Department announced Friday. The settlement resolves a federal lawsuit filed in 2020 that accused the retail giant of failing to report suspicious orders...
